In this February 2021 volume of Neurosurgery News, University of Pittsburgh Department of Neurological Surgery presents updates in neurosurgical treatment and patient care.
- David O. Okonkwo, MD, PhD, explains how glial fibrillary acidicprotein (GFAP) can accurately determine the severity of a brain injury through a blood test
- Raymond F. Sekula, Jr., MD, MBA, describes how the Center for Brainstem and Cranial Nerve Disorders is working to better understand which patients with trigeminal neuralgia (TN) can benefit from surgical intervention
- Jorge Gonzalez-Martinez, MD, PhD, describes the stereotaxic exploration of the epileptic brain
- Pascal Zinn, MD, PhD, identifies Glioblastoma multiforme (GBM) management
- Marco Capogrosso, PhD, explains spinal cord stimulation (SCS), initially developed for the treatment of refractory pain, is now finding great momentum as a tool to restore movement after spinal cord injury
- Robert Friedlander, MD, MA, department chairman, provides a welcoming New Year message
Upon completion of this activity, participants should be able to:
- Explain how SEEG is performed and data is interpreted
- Recall in-vitro brain modeling using cerebral organoids
- Describe the current glioblastoma (GBM) treatment paradigm and explain why it remains static in brain cancer and survival rates are not improving
- Describe orgaoid technology
- Identify the new potential clinical applications of Spinal Cord Stimulation and recognize the neural targets of Epidural Spinal Cord Stimulation
- Describe potential prosthetic versus therapeutic approaches
- Implement optimal imagining tools to identify classical trigeminal neuralgia disorder and microvascular decompression
Drs. Eubanks, Habib, Okonkwo, Sekula, Stone have reported no relevant relationships with entities producing health care goods or services.
Dr. Gonzalez-Martinez has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Consultant: Zimmer Biomet
- Other: Neurologic
Dr. Zinn has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Grant/Research Support: UPMC startup funds
Dr. Capogrosso has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Grant/Research Support: GTX Medicals
Dr. Friedlander has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Consultant: NeuBase Therapeutics, DiFusion Inc.
- Grant/Research Support: NIH, Clear Thoughts Foundation
All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates enduring material activity for a maximum of .50 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.
Release Date: 1/22/2021 | Last Modified On: 1/22/2021 | Expires: 1/24/2022